Health-Chem Corporation (HCLC)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0001 - Volume
260 - Avg. Volume
0 - Market Cap (intraday)
73,985 - Beta (5Y Monthly) 43.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.
55
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: HCLC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HCLC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HCLC
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.01
Enterprise Value/EBITDA
0.27
Financial Highlights
Profitability and Income Statement
Profit Margin
-15.87%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
5.28M
Net Income Avi to Common (ttm)
-837k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.85M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: HCLC
HCLC does not have Company Insights